| Product Code: ETC7635428 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Next Generation Sequencing Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Next Generation Sequencing Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Next Generation Sequencing Market - Industry Life Cycle |
3.4 Ireland Next Generation Sequencing Market - Porter's Five Forces |
3.5 Ireland Next Generation Sequencing Market Revenues & Volume Share, By Sequencing Type, 2021 & 2031F |
3.6 Ireland Next Generation Sequencing Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Ireland Next Generation Sequencing Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.8 Ireland Next Generation Sequencing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.9 Ireland Next Generation Sequencing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Ireland Next Generation Sequencing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for personalized medicine and precision healthcare |
4.2.2 Technological advancements in next-generation sequencing techniques |
4.2.3 Growing adoption of next-generation sequencing in research and clinical diagnostics |
4.3 Market Restraints |
4.3.1 High cost associated with next-generation sequencing instruments and consumables |
4.3.2 Lack of skilled professionals proficient in next-generation sequencing techniques |
4.3.3 Regulatory challenges and data privacy concerns in genomic sequencing |
5 Ireland Next Generation Sequencing Market Trends |
6 Ireland Next Generation Sequencing Market, By Types |
6.1 Ireland Next Generation Sequencing Market, By Sequencing Type |
6.1.1 Overview and Analysis |
6.1.2 Ireland Next Generation Sequencing Market Revenues & Volume, By Sequencing Type, 2021- 2031F |
6.1.3 Ireland Next Generation Sequencing Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 Ireland Next Generation Sequencing Market Revenues & Volume, By Targeted Resequencing, 2021- 2031F |
6.1.5 Ireland Next Generation Sequencing Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.1.6 Ireland Next Generation Sequencing Market Revenues & Volume, By RNA Sequencing, 2021- 2031F |
6.1.7 Ireland Next Generation Sequencing Market Revenues & Volume, By CHIP Sequencing, 2021- 2031F |
6.1.8 Ireland Next Generation Sequencing Market Revenues & Volume, By De Novo Sequencing, 2021- 2031F |
6.1.9 Ireland Next Generation Sequencing Market Revenues & Volume, By Others, 2021- 2031F |
6.1.10 Ireland Next Generation Sequencing Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Ireland Next Generation Sequencing Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Ireland Next Generation Sequencing Market Revenues & Volume, By Instruments, 2021- 2031F |
6.2.3 Ireland Next Generation Sequencing Market Revenues & Volume, By Reagents and Consumables, 2021- 2031F |
6.2.4 Ireland Next Generation Sequencing Market Revenues & Volume, By Software and Services, 2021- 2031F |
6.3 Ireland Next Generation Sequencing Market, By Product Type |
6.3.1 Overview and Analysis |
6.3.2 Ireland Next Generation Sequencing Market Revenues & Volume, By Instruments, 2021- 2031F |
6.3.3 Ireland Next Generation Sequencing Market Revenues & Volume, By Reagents and Consumables, 2021- 2031F |
6.3.4 Ireland Next Generation Sequencing Market Revenues & Volume, By Software and Services, 2021- 2031F |
6.4 Ireland Next Generation Sequencing Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Ireland Next Generation Sequencing Market Revenues & Volume, By Biomarker and Cancer, 2021- 2031F |
6.4.3 Ireland Next Generation Sequencing Market Revenues & Volume, By Drug Discovery and Personalized Medicine, 2021- 2031F |
6.4.4 Ireland Next Generation Sequencing Market Revenues & Volume, By Genetic Screening, 2021- 2031F |
6.4.5 Ireland Next Generation Sequencing Market Revenues & Volume, By Diagnostics, 2021- 2031F |
6.4.6 Ireland Next Generation Sequencing Market Revenues & Volume, By Agriculture and Animal Research, 2021- 2031F |
6.4.7 Ireland Next Generation Sequencing Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Ireland Next Generation Sequencing Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 Ireland Next Generation Sequencing Market Revenues & Volume, By Academic Institutes and Research Centers, 2021- 2031F |
6.5.3 Ireland Next Generation Sequencing Market Revenues & Volume, By Hospitals and Clinics, 2021- 2031F |
6.5.4 Ireland Next Generation Sequencing Market Revenues & Volume, By Pharmaceutical and Biotechnology Companies, 2021- 2031F |
6.5.5 Ireland Next Generation Sequencing Market Revenues & Volume, By Others, 2021- 2031F |
7 Ireland Next Generation Sequencing Market Import-Export Trade Statistics |
7.1 Ireland Next Generation Sequencing Market Export to Major Countries |
7.2 Ireland Next Generation Sequencing Market Imports from Major Countries |
8 Ireland Next Generation Sequencing Market Key Performance Indicators |
8.1 Percentage increase in research funding allocated to genomics and personalized medicine |
8.2 Number of research collaborations between academic institutions, biotech companies, and healthcare providers in the field of next-generation sequencing |
8.3 Rate of adoption of next-generation sequencing in clinical diagnostics and treatment decision-making |
9 Ireland Next Generation Sequencing Market - Opportunity Assessment |
9.1 Ireland Next Generation Sequencing Market Opportunity Assessment, By Sequencing Type, 2021 & 2031F |
9.2 Ireland Next Generation Sequencing Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 Ireland Next Generation Sequencing Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.4 Ireland Next Generation Sequencing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.5 Ireland Next Generation Sequencing Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Ireland Next Generation Sequencing Market - Competitive Landscape |
10.1 Ireland Next Generation Sequencing Market Revenue Share, By Companies, 2024 |
10.2 Ireland Next Generation Sequencing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here